Literature DB >> 10491047

Keloids and hypertrophic scars.

R S English1, P D Shenefelt.   

Abstract

BACKGROUND: Keloids and hypertrophic scars are benign fibrous growths that occur after trauma or wounding of the skin and present a major therapeutic dilemma to the dermatologist because of frequent recurrences.
OBJECTIVE: The purpose of this study is to review the pertinent literature and provide updated information on keloids and hypertrophic scars that will enable the physician to better understand and treat these lesions.
METHODS: A Medline literature search was performed for relevant publications.
RESULTS: Traditional treatment methods which have been effective include a combination of surgery with intralesional steroids and/or radiotherapy, silicone gel sheeting, pressure, and cryotherapy. Recently newer modalities shown to be effective include pulsed dye laser, interferon alfa-2b, and cultured epithelial autografts.
CONCLUSION: Keloids and hypertrophic scars present a major therapeutic dilemma to the dermatologist because of frequent recurrences. A better understanding of keloid pathogenesis may lead to improved therapies by which keloid growth and regrowth may be obviated. Although optimal treatment for keloids remains undefined, successful treatment can be obtained through a multimodality approach. Regardless of the technique employed, an observation period of at least 2 years is necessary to rule out recurrence.

Entities:  

Mesh:

Year:  1999        PMID: 10491047     DOI: 10.1046/j.1524-4725.1999.98257.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  49 in total

Review 1.  Therapy of auricular keloids: review of different treatment modalities and proposal for a therapeutic algorithm.

Authors:  K Froelich; R Staudenmaier; N Kleinsasser; R Hagen
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-13       Impact factor: 2.503

2.  Keloid of the conjunctiva simulating a conjunctival malignancy.

Authors:  Jignesh G Parikh; Rahul N Khurana; Michael M Lai; Anthony Rodriguez; Narsing A Rao
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

3.  Clinical characteristics of auricular keloids treated with surgical excision.

Authors:  So Young Park; Guen-Ho Lee; Jung Mee Park; Sang-Gyun Jin; Jeong-Hoon Oh
Journal:  Korean J Audiol       Date:  2012-12-18

Review 4.  [Therapy of keloids].

Authors:  S Karrer
Journal:  Hautarzt       Date:  2007-11       Impact factor: 0.751

5.  A novel triple medicine combination injection for the resolution of keloids and hypertrophic scars.

Authors:  Nilesh N Goyal; Michael H Gold
Journal:  J Clin Aesthet Dermatol       Date:  2014-11

6.  Aesthetic assessment in periciliary "v-incision" versus conventional external dacryocystorhinostomy in Asians.

Authors:  Danny Siu-Chun Ng; Edwin Chan; Derek Kim-Hun Yu; Simon Tak-Chuen Ko
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-10       Impact factor: 3.117

7.  Statistical analysis of factors affecting re-operative times in paediatric patients with scar deformity after deep second-degree burn injury.

Authors:  Baoguo Chen; Xiaotong Yue; Ruijuan Zhang; Huifeng Song
Journal:  Int Wound J       Date:  2018-03-30       Impact factor: 3.315

8.  Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens.

Authors:  Gisele V Oliveira; Hal K Hawkins; David Chinkes; Ann Burke; Andre Luiz Pasqua Tavares; Marcia Ramos-e-Silva; Thomas B Albrecht; Gregory T Kitten; David N Herndon
Journal:  Int Wound J       Date:  2009-12       Impact factor: 3.315

9.  Clinical and histologic effects from CO2 laser treatment of keloids.

Authors:  Gianfranco Nicoletti; Francesco De Francesco; Carmine Michele Mele; Chiara Cataldo; Roberto Grella; Sergio Brongo; Marina Accardo; Giuseppe Andrea Ferraro; Francesco D'Andrea
Journal:  Lasers Med Sci       Date:  2012-08-21       Impact factor: 3.161

10.  Investigating the role of P311 in the hypertrophic scar.

Authors:  Jianglin Tan; Xu Peng; Gaoxing Luo; Bing Ma; Chuan Cao; Weifeng He; Shunzong Yuan; Shirong Li; John A Wilkins; Jun Wu
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.